Capital Clean Energy Carriers Corp. (CCEC) has formed a 50/50 joint venture with CMA CGM S.A. to construct and operate a 20,000 cbm dual-fuel LNG bunkering vessel, marking CCEC's entry into the LNG bunkering market and marine fuel supply. A shipbuilding contract worth $82.8 million has been signed with Nantong CIMC Sinopacific Offshore & Engineering for the vessel, expected for delivery in Q3 2028. The venture also anticipates a 12-year time charter with a CMA CGM and TotalEnergies partnership, establishing a new revenue stream and supporting cleaner fuel infrastructure.

Cuprina Holdings (Cayman) Limited announced it has regained compliance with Nasdaq Capital Markets Listing Requirements. The company had previously faced delisting for its share price falling below $1.00 for 30 consecutive business days but has since met the minimum bid price requirement. As a result, a previously scheduled hearing before the Nasdaq Hearing Panel has been canceled, and the company's shares will continue to trade under the symbol "CUPR."

Cuprina Holdings (CUPR) has successfully regained compliance with Nasdaq's minimum bid price requirement, ensuring its Class A Ordinary Shares will continue to be listed and traded on the Nasdaq Capital Market. The company had previously faced a delisting determination for failing to maintain a $1.00 minimum bid price and appealed, but the scheduled hearing has now been cancelled due to its restored compliance. CEO David Quek expressed gratification, emphasizing the company's commitment to growing its biomedical businesses.

Netflix (NFLX) stock has declined by approximately 25% since its Q1 2026 earnings report, pressured by cautious full-year revenue guidance despite beating revenue expectations. Analysts, however, project significant upside due to the company's advertising tier and live sports acceleration, with management noting substantial growth potential in non-Anglophone markets and a current 5% global TV viewership share. While Netflix is seen as a strong investment, some AI stocks are suggested to offer greater upside and less downside risk.

This article analyzes Bancolombia S.A.'s NYSE-listed ADR, focusing on its valuation against broader Latin American bank peers. It discusses key metrics like P/E and P/B multiples, ROE, and the impact of interest rates and non-interest income on its earnings profile. The report also highlights the bank's capital adequacy, asset quality, dividend policy, and the influence of Colombian macro conditions on its stock performance.

This article provides the price to earnings ratio for Amgen Inc. Shs Cert Deposito Arg Repr 0.033333 Shs (BCBA:AMGN.CI). It notes that the market is currently closed with no trades. The article is part of a financial data overview from TradingView focusing on the Argentinian stock market.

Analysts have raised the average 12-month price target for Steel Dynamics, Inc. (STLD) stock from $267.45 to $270.64, with individual forecasts ranging from $227 to $310. This updated target suggests a potential 3% downside based on the latest closing price. Despite this, the consensus rating from 14 analysts remains "Buy," with a breakdown of 8 Buys, 4 Holds, and 2 Sells.

Analysts have adjusted their average 12-month price target for Abbott Laboratories (ABT) stock to $115.5, a slight decrease from $116.32. This new target implies a potential upside of approximately 29% from its June 11 closing price. The consensus rating among 29 analysts remains a "Buy," with 23 recommending Buy and 6 recommending Hold.

Medtronic's average 12-month stock price target has been adjusted down to $96.72 from $97.32, according to 25 analysts. This new target suggests a potential upside of approximately 20% from the June 11 closing price. The stock maintains a "Buy" consensus rating from 33 analysts.

Analysts have raised the average 12-month price target for TD SYNNEX Corporation (SNX) stock from $260.55 to $265.09, with individual forecasts ranging from $200 to $320. Based on the June 11 closing price, this new target suggests a potential 4% downside. Despite this, the consensus rating from 13 analysts remains a "Buy," with 10 recommending Buys and 3 recommending Holds.